Price T Rowe Associates Inc Global Blood Therapeutics, Inc. Transaction History

Price T Rowe Associates Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$32.4 - $68.18 $82.2 Million - $173 Million	-2,535,686 Reduced 81.62%	571,115 $38.9 Million
Q2 2022 Aug 15, 2022	SELL	$22.3 - $37.39 $1.66 Million - $2.79 Million	-74,498 Reduced 2.34%	3,106,801 $99.3 Million
Q1 2022 May 16, 2022	SELL	$25.68 - $35.59 $2.04 Million - $2.83 Million	-79,386 Reduced 2.43%	3,181,299 $110 Million
Q4 2021 Feb 14, 2022	SELL	$24.9 - $40.26 $3.67 Million - $5.93 Million	-147,309 Reduced 4.32%	3,260,685 $95.4 Million
Q3 2021 Nov 15, 2021	SELL	$25.48 - $37.34 $8.97 Million - $13.2 Million	-352,201 Reduced 9.37%	3,407,994 $86.8 Million
Q2 2021 Aug 16, 2021	SELL	$32.46 - $43.42 $3.7 Million - $4.94 Million	-113,871 Reduced 2.94%	3,760,195 $132 Million
Q1 2021 May 17, 2021	SELL	$38.94 - $50.85 $7.36 Million - $9.61 Million	-189,057 Reduced 4.65%	3,874,066 $158 Million
Q4 2020 Feb 16, 2021	BUY	$37.65 - $63.77 $153 Million - $259 Million	4,063,123 New	4,063,123 $176 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.